1. Introduction {#sec1}
===============

Numerous agents, from endogenous and exogenous sources, can induce DNA damage in cell genome. At times, the lesion induction mechanisms of these agents are mediated by reactive oxygen species (ROS) production. These compounds can play a role in the initial events involved in aging, mutagenesis, and cancer \[[@B1], [@B2]\].

Stannous salts, used in different areas of human daily life, and ultraviolet radiation A (UVA or near-UV light---320--400 nm), a fraction from solar light that reaches the Earth surface, are examples of exogenous agents which produce lesions in DNA by ROS generation. Different forms of stannous salts are used in food industry \[[@B3]--[@B6]\], but major concern lies in its inorganic form such as stannous chloride (SnCl~2~), since this is widely used in nuclear medicine as a reducing agent in the labeling of molecules and cells with technetium-99 m \[[@B7], [@B8]\]. In this case, SnCl~2~ is intravenously administered to the patient \[[@B8]\].

Several authors have been demonstrated the cytotoxic, genotoxic, and mutagenic effects of SnCl~2~ and UVA. As to SnCl~2~, it was described that this salt is able to produce ROS in a Fenton-like reaction, inducing lethality in *Escherichia coli* (*E. coli*) \[[@B9]\], cytotoxicity and genotoxicity in eukaryotic cells \[[@B10]\], and genotoxicity in plasmid DNA \[[@B11]--[@B13]\]. Mutagenic properties were also reported to SnCl~2~, being 8-hydroxyguanine (8-oxodGuo) the predominant lesion, accountable for G:C-T:A transversions \[[@B14]\], as well as mutagenicity in yeast and bacteria \[[@B15]\]. Concerning UVA, ROS production was observed in bacteria \[[@B16]\], calf thymus DNA, and HeLa cells \[[@B17]\]. In 1986, Caldeira de Araujo and Favre \[[@B18]\], demonstrated, by using the SOS chromotest assay, that this radiation was able to induce SOS functions in *E. coli*, suggesting that this agent had mutagenic properties. Recent works have pointed out that UVA mutagenic effects are associated to 8-oxodGuo production \[[@B17], [@B19], [@B20]\]. Another phenomenon observed by Favre and coworkers, in 1985 \[[@B21]\], was that UVA sublethal doses were able to induce growth delay effect in *E. coli*.

In addition to many papers pointing toward ROS production by SnCl~2~ and UVA, some researchers have demonstrated that these agents are also able to induce a direct effect on DNA. For instance, De Mattos and collaborators \[[@B22]\] suggested that stannous ions were able to bind to DNA, inducing ROS formation very close to this target; and Courdavault et al. \[[@B23]\], upon studying human fibroblasts and keratinocytes submitted to UVA, described production of thymine cyclobutane dimer (CPD) level higher than both 8-oxodGuo and single strand breaks. Similar results were found in Chinese hamster ovary \[[@B24]\] and in rodent cells \[[@B25]\].

Different authors have pointed to base excision repair (BER) as the most important system capable of repairing oxidative damage from broad oxidative sources \[[@B26], [@B27]\]. Thus, a number of studies have been pointed to the participation of BER enzymes in lesion repair induced by SnCl~2~ \[[@B14], [@B28]\] and UVA \[[@B29]--[@B32]\]. In BER pathway, the injured base excision is initiated by the action of a class of DNA repair enzymes called DNA glycosylases, which recognize oxidative lesions and sever these from DNA. The initial enzymatic event during BER produces abasic (AP) sites in DNA. The removal of AP sites is initiated by a second class of BER enzymes called AP endonucleases. AP sites are extremely toxic to cells and can be generated in DNA during normal aerobic metabolism or by exogenous agents, such as ionizing radiation, UV light, and hydrogen peroxide (H~2~O~2~) \[[@B26]\].

The XthA protein accounts for 90% of AP endonucleolytic activity found in *E. coli*, being an important member of the BER mechanism \[[@B26]\]. The *E. coli xthA* mutants are sensitive to oxidative lesions produced by agents such as near-UV and H~2~O~2~ \[[@B33]\]. Most of the residual AP endonucleolytic activity present in *xthA* mutants is encoded by the *nfo* gene \[[@B34]\]. The endonuclease IV (Nfo protein), codified by *nfo* gene, recognizes and cleaves DNA in a similar way to exonuclease III \[[@B35]\], albeit some authors suggest that the Nfo enzyme is able to recognize lesions not recognized by exonuclease III \[[@B36]\]. Moreover, endonuclease IV is the only BER protein which, besides existing constitutively, can have its expression increased by the SoxRS system \[[@B37]\]. It has recently been described that endonuclease IV plays a role in an alternative pathway to classic BER, called nucleotide incision repair (NIR) \[[@B38]\], in which it cleaves DNA generating terminus which constitutes the DNA polymerase target. Thus, this pathway has the advantage of avoiding the genotoxic intermediates generated in BER mechanism \[[@B38]\].

Based on the above, we decided to investigate cytotoxicity and genotoxicity induced by the pretreatment of UVA followed by SnCl~2~ incubation in *E. coli* BER mutants. Cytotoxicity was assessed through bacterial survival assays, and genotoxicity was studied by using alkaline gel electrophoresis, described by De Mattos et al. 2008 \[[@B39]\].

2. Material and Methods {#sec2}
=======================

2.1. Chemicals {#sec2.1}
--------------

Stannous chloride (SnCl~2~·2H~2~O) and sodium dodecyl sulfate (SDS) were acquired from Sigma Chemical Co. (USA). Sodium chloride and ethylene diaminetetracetic acid (EDTA) were obtained from Lafan (Brazil). Sodium hydroxide (NaOH) and Tris (hydroxymethyl) amino-methane were obtained from Nuclear (Brazil). Normal point agarose (NPA), low-melting point agarose (LMPA) and ethidium bromide were acquired from Invitrogen (Brazil).

2.2. Bacterial Strains {#sec2.2}
----------------------

The strains and plasmid used and their relevant genetic characteristics for this work are listed in [Table 1](#tab1){ref-type="table"}.

2.3. Growth Medium {#sec2.3}
------------------

Bacterial cells were grown overnight at 37°C, with shaking in LB medium \[[@B40]\]. A starting culture for experiments was taken from overnight samples, and the cells were grown in the same medium up to exponential phase (1-2 × 10^8^ cells/ml); harvested by centrifugation (2.940 × g; 15 min; 4°C), washed twice and suspended in 0.9% NaCl.

2.4. Survival of Escherichia coli {#sec2.4}
---------------------------------

Bacterial cultures in mid-log growth phase, suspended in 0.9% NaCl, were divided in two fractions, each containing 2 ml. One of them was illuminated with UVA (Phillips lamp, 125 W, emitting more than 95% in 365 nm) for 1 hour, at 25 J/m^2^/s, totaling 90 kJ/m^2^. During irradiation, a glass filter was used to cut off lower wavelengths. Following, 1 ml of each fraction (illuminated or not) was taken and incubated with SnCl~2~ (25 *μ*g/ml), during 1 hour, with shaking. After this, it was obtained four samples: control (not treated), treated with SnCl~2~, UVA-irradiated, and pre-illuminated plus SnCl~2~ incubation.

Aliquots from each fraction were taken every 20 minutes, appropriately diluted in 0.9% NaCl solution and then spread onto LB medium. After 18 hours of incubation at 37°C, the colonies were counted and the number of viable cells (*N*), obtained for the various incubation times, was matched to that observed for time zero (*N*~0~), as a measure of survival fractions. All experiments were done at least three times and data plotted represent the mean values with their respective standard deviations. Untreated controls did not show significant variation (*P* \> .05) in cell number along the time (data not shown). Data collected were analyzed by ANOVA, followed by the Tukey\'s multiple comparison test, using GraphPad Prism software, version 4.0, with a 5% significance level. Before ANOVA statistical analysis, the normal distribution of data was ensured by Kolgomorov-Smirnov test.

2.5. Alkaline Gel Electrophoresis {#sec2.5}
---------------------------------

All *E*. *coli* strains assayed with this methodology were prepared as described above, in survival experiments. Being the volume of cultures increased to 6 ml and the SnCl~2~-treatment time reduced for 40 minutes. Following treatments, 1.5 ml from each fraction was centrifuged and the protocol described by De Mattos et al. 2008 \[[@B39]\] was done with the aim to detect DNA strand breaks induced by SnCl~2~, UVA, and pre-illumination with UVA, followed by SnCl~2~ incubation. The *E. coli* residual fractions (4.5 ml) were centrifuged, suspended in fresh LB medium and incubated with shaking for 90 minutes, at 37°C. Aliquot (1.5 ml) from each sample was taken every 30 minutes, in order to verify the lesions repair induced by the agents used in this work. Briefly, collected aliquots were centrifuged, suspended in cold TE and mixed with low melting point agarose. The mixture was placed in acrylic container to form squared blocks. They were incubated in lysing solution and placed in alkaline normal agarose gel. It was submitted to electrophoresis, neutralized, and then stained in ethidium bromide. Alkaline electrophoresis assays were carried out at least three times to confirm the obtained data and the best gels were selected. The images obtained from alkaline electrophoresis were analyzed using the software Image J 1.33u version to quantify the DNA strand breaks. The collected data were submitted to chi-square test (*χ*^2^), adopting 5% as significance level.

3. Results and Discussion {#sec3}
=========================

Survival experiments have shown, for all strains tested, that the UV dose used in this work (90 kJ/m^2^) was not able to induce bacterial inactivation, being considered sublethal (data not shown). Experiments carried out with SnCl~2~ (25 *μ*g/mL) have shown no significant differences (*P* \> .05) among inactivation levels produced in AB1157 strain (wild type), BW9091 (*xth*A), and BW372 (*nth*) mutants. However, a significant difference (*P* \< .001) was observed among wild type, BW527 (*nfo*) and BH20 (*fpg*) strains ([Figure 1](#fig1){ref-type="fig"}), being *nfo* mutant the most sensitive. These results indicate that endonuclease IV and Fpg proteins must be important in the repair of SnCl~2~-induced lesions. A significant difference (*P* \< .001) can be observed, in the same figure, between *fpg* and *nth* mutants. This result was expected, as Friedberg and coworkers, 2006 \[[@B26]\] reported that the Fpg enzyme recognizes oxidative lesions, such as 8-oxodGuo. Moreover, SnCl~2~ may be able to induce this kind of damage, as supported by Cabral et al. 1998 \[[@B14]\]. It can also be ascertained, in the same figure, that endonuclease IV enzyme could be more important than *xth*A gene product. This assertion is based on the fact that, in our experimental conditions, BW9091 was less sensitive than BW527 to the treatment, which could be due to *nfo* gene product performance that works in the first one.

Regarding the UVA pre-treatment, followed by SnCl~2~ incubation, it was found that this association produced a synergistic lethal effect in all strains tested, when compared to SnCl~2~ alone (*P* \< .001).[Figure 2](#fig2){ref-type="fig"}presents the results obtained with wild type (AB1157) strain and BH20, BW372, BW9091, and BW527 mutants, pre-illuminated with UVA, followed by SnCl~2~ incubation. In this case, a significant difference (*P* \< .001) was observed among these. As it had occurred with the SnCl~2~ treatment, BW527 (*nfo*) mutant had the lowest survival fraction in response to the association of UVA with SnCl~2~. This finding corroborates, furthermore, that the product of *nfo* gene plays an important role in the repair of the damage induced, not only by SnCl~2~, but also by the association of this agent with UVA. In these treatment conditions, BH20 (*fpg*) strain was more sensitive than BW372 (*nth*) mutant, suggesting, again, that Fpg enzyme is more efficient than Nth to recognize and remove lesions produced by the association of both agents.

In order to ascertain the actual role of endonuclease IV in the *E. coli* survival to SnCl~2~ and UVA + SnCl~2~ treatments, BW527 (*nfo*) strain was transformed with pBW21 plasmid carrying the *nfo* gene, and submitted to bacterial inactivation experiments. The wild type strain (AB1157) was also transformed with pBW21 plasmid. The results demonstrated, for SnCl~2~ treatment, that BW527 + pBW21 presented the same inactivation level (*P* \> .05) of AB1157 + pBW21, whereas a significant difference was obtained between these strains and BW527 (*P* \< .001) ([Figure 3](#fig3){ref-type="fig"}). Similar results were obtained when the strains were pre-illuminated with UVA, and then incubated with SnCl~2~ ([Figure 4](#fig4){ref-type="fig"}). So, this data demonstrated that Nfo enzyme accounts for *E. coli* survival and reinforces the fact that the lesions induced by SnCl~2~ and by its association with UVA constitute Nfo protein targets.

The results found in this work are similar to those obtained by Levin and Demple 1996 \[[@B41]\] when studying the bleomicine effect on wild type (AB1157) and *nfo* mutant (BW527) *E. coli* cells. These authors introduced a plasmid DNA containing the *nfo* gene in AB1157 strain and observed that this strain was able to repair the bleomicine-induced lesions. So, it was shown that Nfo overexpression, in vivo, contributes to the elimination of bleomicine-induced DNA lesions. In this manner, it was clear that endonuclease IV would be more important than exonuclease III in bleomicine-induced damage repair, since its level is the same as in the *nfo* mutant and in the strain overexpressing Nfo protein.

To better understand the damage and repair mechanisms induced by the agents used in this work, alkaline gel electrophoresis was assayed to detect strand breaks in bacterial genome. Results obtained with this procedure have shown that SnCl~2~, UVA, and its association with SnCl~2~, in pre-illumination condition, were able to produce DNA strand breaks in all tested strains. Furthermore, the UVA association with SnCl~2~ generated a higher number of DNA strand breaks, when compared to SnCl~2~ treatment (*P* \< .0001).

The gel densitometrical analysis revealed, for UVA treatment, that AB1157 (wild type) was the strain presenting the highest efficiency in lesions-induced repair by this radiation ([Figure 5](#fig5){ref-type="fig"}). This result was expected, since this strain possesses all active repair mechanisms.

When comparing the simple mutants (BH20, BW372, BW527, and BW 9091), it was observed that BH20 (*fpg*) strain showed the slowest DNA strand break repair kinetics ([Figure 6](#fig6){ref-type="fig"}). This result agrees with the literature, since the *fpg* gene product is able to recognize 8-oxodGuo lesions \[[@B26], [@B27], [@B42]\]. As exposed previously, UVA radiation can induce ROS generation which can lead to 8-oxodGuo formation \[[@B43], [@B44]\]. The BH20 strain display delay in lesion restoration upon a lack of Fpg.

The BW372 ([Figure 7](#fig7){ref-type="fig"}), BW527 ([Figure 8](#fig8){ref-type="fig"}), and BW9091 ([Figure 9](#fig9){ref-type="fig"}) strains were statistically identical, regarding UVA-induced lesion repair capacity. However, these mutants were more efficient in lesion restoration than BH20 (*P* \< .05), a fact which can be explained by Fpg protein functioning. This data supports the hypothesis that Fpg enzyme could be important in recognizing UVA-induced damages.

Nevertheless, the results pointed to Nth, Nfo, and XthA protein participation in a given repair step, since the strains deficient in these enzymes were not so efficient, as the wild type strain (AB1157), in lesion repair. In this case, it should be remembered that Nth protein can also attack different residues generated by oxidative agents \[[@B26]\]. In agreement, it was shown here that Fpg is the preferential enzyme in recognizing UVA-induced lesions, since BH20 (*fpg*) displayed a delay in lesion repair when compared to BW372 (*nth*). This assertion is based on the fact that, during BH20 repair kinetics, a decrease was not observed in DNA strand break number between the times 30 and 60 minutes of repair (*P* \> .05---[Figure 6](#fig6){ref-type="fig"}, lanes 6 and 9). In contrast, in BW372 strain, the maximum repair level was obtained in 60 minutes ([Figure 7](#fig7){ref-type="fig"}, lane 9).

The residues left at the lesion site by Nth or Fpg enzymes action need to be processed by AP endonucleases to complete BER repair. These residues constitute exonuclease III protein targets \[[@B45]\], and for this fact, BW9091 strain (*xthA*) was not able to complete the repair ([Figure 9](#fig9){ref-type="fig"}) as efficiently as in the wild type. As described by Levin et al. 1988 \[[@B35]\] endonuclease IV (Nfo) protein can also take part in the ROS lesion-induced repair, since this enzyme possesses a similar substratum to that of exonuclease III \[[@B26]\]. Thus, in the absence endonuclease IV (BW527), restoration was not successfully completed after 90 minutes ([Figure 8](#fig8){ref-type="fig"}), when compared with the wild type.

Comparing BW9091 (*xthA*) and BW527 (*nfo*) strains, it was observed that the latter was slower in the repair process than the former, since the DNA strand breaks number in BW527 remains the same between the times 30 and 60 minutes (*P* \> .05---[Figure 8](#fig8){ref-type="fig"}, lanes 6 and 9). This data could suggest that Nfo enzyme is more important than XthA protein in UVA-induced lesions repair. Such idea was supported by gel densitometrical analysis of double mutants lacking endonuclease IV which were least efficient in the repair (data not shown).

As cited above, the endonuclease IV is the only inducible BER enzyme \[[@B37]\] and the UVA dose employed in this study is known to induce growth delay in *E. coli* \[[@B46]\]. Thus, this could explain the least efficiency of BH20 (*fpg*) in UVA-induced lesion repair in that, even possessing Nfo enzyme, its synthesis would be partially inhibited by the growth delay mechanism. Another evidence of growth delay is based on the same behavior presented by BW527 (*nfo*), BW9091 (*xthA*), BW372 (*nth*), and BW434 (*xthA*-*nth*---data not shown) strains. The mutants which possess the Nfo protein were not more efficient in repairing the damages than BW527, suggesting that *nfo* gene translation could be inhibited by the growth delay.

The gel densitometrical analysis revealed, for SnCl~2~ treatment, that AB1157 ([Figure 5](#fig5){ref-type="fig"}) was the strain which repaired the SnCl~2~-induced lesions with the most efficiency, as expected for a wild type strain.

The simple mutant analysis showed that BW527 (*nfo*) strain presented the most delay in the SnCl~2~-lesion-induced repair ([Figure 8](#fig8){ref-type="fig"}), being followed by BW9091 (*xthA*---[Figure 9](#fig9){ref-type="fig"}), BH20 (*fpg*---[Figure 6](#fig6){ref-type="fig"}), and BW372 (*nth*---[Figure 7](#fig7){ref-type="fig"}) strains. These results point to the important roles developed by AP endonucleases (Nfo and XthA) in processing AP sites, generated by DNA glicosylases enzymes (Fpg and Nth).

When BH20 ([Figure 6](#fig6){ref-type="fig"}) and BW372 ([Figure 7](#fig7){ref-type="fig"}) strains were compared, it was observed that BH20 (*fpg*) showed the least capacity in restoring SnCl~2~-induced damages. As literature reports, SnCl~2~ is able to induce 8-oxodGuo lesions \[[@B14]\], which constitute Fpg targets \[[@B26], [@B42]\]. So, despite the description that endonuclease III (Nth) could recognize and remove oxidative damages \[[@B26]\], the data obtained in this study with BH20 and BW372 mutants suggest that SnCl~2~ would be producing 8-oxodGuo, thereby reinforcing the results of Cabral et al. 1998 \[[@B14]\]. In addition, Fpg enzyme would also be required in processing this lesion.

The comparison between BW527 ([Figure 8](#fig8){ref-type="fig"}) and BW9091 ([Figure 9](#fig9){ref-type="fig"}) revealed that the Nfo deficient strain (BW527) remained with the most DNA strand breaks number after repair kinetics, suggesting that Nfo enzyme would play a more important role than XthA in SnCl~2~-induced damage repair.

Literature data showed that, among BER enzymes, exonuclease III was required to restore SnCl~2~-induced lesions \[[@B14]\]. However, in this study, this fact was not observed with the same intensity, even when using *xthA* deleted strain (BW9109---data not shown). Thus, SnCl~2~ could be producing damages which would be preferentially recognized by endonuclease IV, as occurring with the chemical agents tert-butyl hydroperoxide and bleomicine, which produce lesions not recognized by exonuclease III, but only by endonuclease IV \[[@B36]\].

It is important to emphasize that despite the fact that endonuclease IV represents only 10% of total AP endonuclease activity \[[@B34]\] it is the sole inducible BER protein \[[@B37]\]. Its expression may be increased 20-fold, when treatments with oxidative agents, such as paraquat, which leads to superoxide radical production, are performed \[[@B47]\]. Thus, in this work, it could be suggested that SnCl~2~ would be inducing an increase in Nfo levels, since this salt is able to produce ROS \[[@B9], [@B11]\]. Then, upon a lack of Nfo, as occurs in BW527 strain, the cell would find it more difficult to repair SnCl~2~-induced lesions. It is known that endonuclease IV increase is depedent on SoxRS system induction \[[@B37]\], in order to ascertain whether SnCl~2~ would be able to induce the SoxRS system and, consequently, endonuclease IV synthesis, SOS chromotest assays were performed. The results obtained were positive (Asad, LMBO, personal communication), corroborating the hypothesis presented in this study.

The Nfo role in SnCl~2~-damage induced repair was reinforced by double mutant analysis (data not shown), in which the strains lacking Nfo protein showed the slowest repair kinetics, when compared to the simple mutants.

When the bacterial strains were pre-illuminated with UVA, followed by SnCl~2~ incubation, a higher DNA strand break number was observed than that secured with SnCl~2~ treatment alone. Once more, the wild type (AB1157) strain presented the highest efficiency in repairing the lesions induced by UVA+SnCl~2~ association ([Figure 5](#fig5){ref-type="fig"}).

As occurring with SnCl~2~ treatment, BW527 (*nfo*) strain once more showed the least efficiency in restoring damages produced by UVA plus SnCl~2~ ([Figure 8](#fig8){ref-type="fig"}). Following BW527, was the BH20 (*fpg*) strain with the lowest ability in repairing UVA + SnCl~2~-induced lesions ([Figure 6](#fig6){ref-type="fig"}) than the other mutants. Moreover, when BH20 was compared to BW372 (*nth*), the latter showed the smallest DNA strand break number at the repair kinetics end ([Figure 7](#fig7){ref-type="fig"}, lane 13). This data suggests that UVA and SnCl~2~ association could be inducing oxidative damages, such as 8-oxodGuo, as previously described \[[@B14], [@B43], [@B44]\] and Fpg enzyme would be preferential in recognizing and removing this damage.

The BW527 ([Figure 8](#fig8){ref-type="fig"}) and BW9091 ([Figure 9](#fig9){ref-type="fig"}) gel analysis reinforced the idea that endonuclease IV would be more important than exonuclease III in restoring UVA + SnCl~2~-induced lesions, in that, at the repair kinetics end, BW527 still presented a higher DNA strand break number ([Figure 8](#fig8){ref-type="fig"}, lane 13). This evidence was corroborated by double mutant analysis (data not shown) in which endonuclease IV deficient strains showed the least efficiency in repairing the UVA and SnCl~2~ induced lesions.

The repair efficiency profiles of the strains treated with both agents follow different patterns from those revealed by the only UVA illuminated strains. Thus, even if the pretreatment with this radiation may induce the growth delay phenomenon, the constitutive existence of Nfo protein will still warrant BW372, BW9091, and BH20 strains major efficiency in repairing the lesions induced by UVA and SnCl~2~ association than that of *nfo* mutant strain (BW527).

Moreover, in addition to its action on AP sites, endonuclease IV is able to recognize and cleave DNA on the 5′ side of various oxidatively damaged bases via NIR, generating the proper ends for DNA repair synthesis \[[@B38]\]. As demonstrated by Ischenko and colleagues, 2006 \[[@B48]\], NIR is essential for handling lethal oxidative DNA lesions. Therefore, our study also could suggest Nfo participation, via NIR, in removing damages induced by SnCl~2~ and UVA + SnCl~2~.

Taken together, our results point to endonuclease IV activity via BER and possible NIR in protecting *E. coli* cells against damages induced by SnCl~2~ and UVA + SnCl~2~.

The authors are grateful to Dr Bernard Weiss for kindly providing *E. coli* strains and plasmid and to Carlos Brown Scavarda for English language support. The study was supported by CAPES and FAPERJ (E-26/152.018/2004; E-26/171.332/2006).

![Survival fraction of *E. coli* AB1157, BH20, BW372, BW9091, and BW527 treated with SnCl~2~. Mid-log phase cells suspended in 0.9% NaCl were treated with 25 *μ*g/mL SnCl~2~ for different incubation times and the specific survival fraction. Survival fraction values are means ± standard deviations of the three isolated experiments.](JBB2010-376218.001){#fig1}

![Survival fraction of *E. coli* AB1157, BH20, BW372, BW9091, and BW527 treated with UVA and SnCl~2~. Mid-log phase cells suspended in 0.9% NaCl were illuminated with 90 kJ/m^2^ UVA, followed by SnCl~2~ (25 *μ*g/mL), for different incubation times and the specific survival fractions. Survival fraction values are means ± standard deviations of the three isolated experiments.](JBB2010-376218.002){#fig2}

![Survival fraction of *E. coli* AB1157, AB1157+pBW21, BW527, and BW527 + pBW21 treated with SnCl~2~. Mid-log phase cells suspended in 0.9% NaCl were treated with 25 *μ*g/mL SnCl~2~ for different incubation times and the specific survival fraction. Survival fraction values are means ± standard deviations of the three isolated experiments.](JBB2010-376218.003){#fig3}

![Survival fraction of *E. coli* AB1157, AB1157+pBW21, BW527, and BW527 + pBW21 treated with UVA and SnCl~2~. Mid-log phase cells suspended in 0.9% NaCl were illuminated with 90 kJ/m^2^ UVA, followed by SnCl~2~ (25 *μ*g/mL), for different incubation times and the specific survival fractions. Survival fraction values are means ± standard deviations of the three isolated experiments.](JBB2010-376218.004){#fig4}

![Alkaline gel electrophoresis of *E. coli* AB1157 treated with SnCl~2~ (25 *μ*g/mL), UVA (90 kJ/m^2^) and pre-illuminated with UVA, followed by SnCl~2~ incubation. Lanes: (1) control; (2) SnCl~2~; (3) UVA; (4) UVA + SnCl~2~; (5) SnCl~2~ 30 minutes; (6) UVA 30 minutes; (7) UVA + SnCl~2~ 30 minutes; (8) SnCl~2~ 60 minutes; (9) UVA 60 minutes; (10) UVA + SnCl~2~ 60 minutes; (11) SnCl~2~ 90 minutes; (12) UVA 90 minutes; (13) UVA + SnCl~2~ 90 minutes.](JBB2010-376218.005){#fig5}

![Alkaline gel electrophoresis of *E. coli* BH20 treated with SnCl~2~ (25 *μ*g/mL), UVA (90 kJ/m^2^) and pre-illuminated with UVA, followed by SnCl~2~ incubation. Lanes: (1) control; (2) SnCl~2~; (3) UVA; (4) UVA + SnCl~2~; (5) SnCl~2~ 30 minutes; (6) UVA 30 minutes; (7) UVA + SnCl~2~ 30 minutes; (8) SnCl~2~ 60 minutes; (9) UVA 60 minutes; (10) UVA + SnCl~2~ 60 minutes; (11) SnCl~2~ 90 minutes; (12) UVA 90 minutes; (13) UVA + SnCl~2~ 90 minutes.](JBB2010-376218.006){#fig6}

![Alkaline gel electrophoresis of *E. coli* BW372 treated with SnCl~2~ (25 *μ*g/mL), UVA (90 kJ/m^2^) and pre-illuminated with UVA, followed by SnCl~2~ incubation. Lanes: (1) control; (2) SnCl~2~; (3) UVA; (4) UVA + SnCl~2~; (5) SnCl~2~ 30 minutes; (6) UVA 30 minutes; (7) UVA + SnCl~2~ 30 minutes; (8) SnCl~2~ 60 minutes; (9) UVA 60 minutes; (10) UVA + SnCl~2~ 60 minutes; (11) SnCl~2~ 90 minutes; (12) UVA 90 minutes; (13) UVA + SnCl~2~ 90 minutes.](JBB2010-376218.007){#fig7}

![Alkaline gel electrophoresis of *E. coli* BW527 treated with SnCl~2~ (25 *μ*g/mL), UVA (90 kJ/m^2^) and pre-illuminated with UVA, followed by SnCl~2~ incubation. Lanes: (1) control; (2) SnCl~2~; (3) UVA; (4) UVA + SnCl~2~; (5) SnCl~2~ 30 minutes; (6) UVA 30 minutes; (7) UVA + SnCl~2~ 30 minutes; (8) SnCl~2~ 60 minutes; (9) UVA 60 minutes; (10) UVA + SnCl~2~ 60 minutes; (11) SnCl~2~ 90 minutes; (12) UVA 90 minutes; (13) UVA + SnCl~2~ 90 minutes.](JBB2010-376218.008){#fig8}

![Alkaline gel electrophoresis of *E. coli* BW9091 treated with SnCl~2~ (25 *μ*g/mL), UVA (90 kJ/m^2^), and pre-illuminated with UVA, followed by SnCl~2~ incubation. Lanes: (1) control; (2) SnCl~2~; (3) UVA; (4) UVA + SnCl~2~; (5) SnCl~2~ 30 minutes; (6) UVA 30 minutes; (7) UVA + SnCl~2~ 30 minutes; (8) SnCl~2~ 60 minutes; (9) UVA 60 minutes; (10) UVA + SnCl~2~ 60 minutes; (11) SnCl~2~ 90 minutes; (12) UVA 90 minutes; (13) UVA + SnCl~2~ 90 minutes.](JBB2010-376218.009){#fig9}

###### 

*Escherichia coli* strains and plasmid with their relevant genetic characteristics for this study.

  Strains   Relevant genetic characteristics              Source
  --------- --------------------------------------------- ------------------------
  AB1157    Wild type                                     Our laboratory
  BH20      *fpg* (formamidopirimidine-DNA glicosilase)   Our laboratory
  BW372     *nth*(endonuclease III)                       B. Weiss, Atlanta, USA
  BW527     *nfo*(endonuclease IV)                        B. Weiss, Atlanta, USA
  BW9091    *xthA* (exonuclease III)                      B. Weiss, Atlanta, USA
  pBW21     *nfo*(endonuclease IV)                        B. Weiss, Atlanta, USA

All strains are derivatives of *E. coli* K-12.
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